Explore evidence

154 /μLMean CD4 count at antiretroviral therapy initiation was 154/μL.

Côte d'IvoireVIH/sidapublished 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 5 observations

33 %Tuberculosis was present in 33% of the HIV-infected patients.

Côte d'Ivoiretuberculose · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

472 per_mm3The median CD4+ cell count among 791 HIV-infected patients was 472/mm³.

Côte d'IvoireVIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

86 deathsAmong 2056 HIV-infected adults in Côte d'Ivoire, 86 deaths were recorded over 9404 patient-years of follow-up.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

61.7 %Gastrointestinal adverse effects were reported by 79 patients (61.7%).

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

5.8 %Of 551 HIV-2 patients on ART, 5.8% died during the median time on ART of 2.4 years.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

68.4 %Among the 95 HIV-2 patients enrolled in the 'success cohort', 65 (68.4%) remained in care.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

8.5 %Among 791 HIV-infected patients in West Africa, 67 (8.5%) were HBsAg positive.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

151 patientsAntiretroviral prophylaxis was prescribed to 151 AEB patients.

Côte d'IvoireVIH/sidaobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

0.63 hazard_ratio6 months of isoniazid preventive therapy reduced all-cause mortality with a hazard ratio of 0.63 (95% CI 0.41 to 0.97) in HIV-infected adults in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

3.7 %HCV prevalence was 3.7% among HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

16 %The West and Central African region registers 16% of new HIV infections worldwide.

Côte d'IvoireVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the Internateurope_pmcdocument of 3 observations

7.8 %Of 422 HIV-2-infected patients, 33 (7.8%) were treated with three NRTIs.

Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations

4 odds_ratioNon-Hodgkin lymphoma was associated with HIV infection with an odds ratio of 4.0.

Côte d'Ivoirenon-Hodgkin lymphoma · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

6.9 %The 6-year probability of death was 6.9% among HIV-infected adults not assigned isoniazid preventive therapy in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

8.5 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of insulin resistance was 8.5 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.

Côte d'Ivoireinsulin resistance · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations

4.1 %The 6-year probability of death was 4.1% among HIV-infected adults assigned isoniazid preventive therapy in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

11.6 odds_ratioAnogenital cancer was associated with HIV infection with an odds ratio of 11.6.

Côte d'Ivoireanogenital cancer · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

40 yearsThe median age of hospitalized HIV-positive adults in West Africa was 40 years.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

86 deathsIn the Temprano trial, 86 participants died during follow-up among 2019 patients followed for 9253 patient-years.

Côte d'IvoireVIH/sidapublished 2020EBioMedicineeurope_pmcdocument of 7 observations

4.37 adjusted_IRRHBsAg-positive individuals with HBV-DNA ≥2000 IU/mL had an adjusted incidence rate ratio for mortality of 4.37 (95% CI = 0.98–13.02) at CD4+ counts 351–500/mm³ compared to HBsAg-negative individuals.

Côte d'Ivoirehépatite B · VIH/sidapublished 2021Antiviral therapyeurope_pmcdocument of 4 observations

4.6 %HIV incidence among female sex workers who never went to school in Côte d'Ivoire was 4.6%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

24.7 per_100_person_yearsThe incidence rate of TB-IRIS was 24.7 per 100 person-years among 453 participants with HIV and tuberculosis.

Côte d'IvoireTB-IRIS · tuberculose · VIH/sidapublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations

0 per_100_person_yearsIn patients with pre-ART CD4 cell count ≥350 cells/μL, incidence of mortality was 0.0 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

3.9 %HIV prevalence among female sex workers in Côte d'Ivoire was 3.9%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988